Paul Barrow1, Patrick Waller, Lesley Wise. 1. Post-Licensing Division, Medicines and Healthcare products Regulatory Agency, London, UK. paul.barrow@mhra.gsi.gov.uk
Abstract
AIMS: To compare Hospital Episode Statistics for 'drug-related' admissions with spontaneously reported adverse drug reactions (ADRs) using UK Yellow Card data for the period 1996-2000. METHODS: This was a descriptive study for which we matched the relevant datasets in respect of time, place, evidence of hospitalization and disease terminology. The principal outcome was the ratio of ADRs leading to hospitalization which had been reported spontaneously during the whole study period. RESULTS: Twenty types of ADR were included and between them there was a wide spread of overall ratios (range 0-130%). The general tendency was for under-reporting on Yellow Cards but for ADRs with a fatal outcome this appeared to be less (range 7-168%). CONCLUSIONS: This study provides some broad indications of the degree of under-reporting of ADRs that occurs despite a clinical diagnosis of a serious ADR being made and recorded.
AIMS: To compare Hospital Episode Statistics for 'drug-related' admissions with spontaneously reported adverse drug reactions (ADRs) using UK Yellow Card data for the period 1996-2000. METHODS: This was a descriptive study for which we matched the relevant datasets in respect of time, place, evidence of hospitalization and disease terminology. The principal outcome was the ratio of ADRs leading to hospitalization which had been reported spontaneously during the whole study period. RESULTS: Twenty types of ADR were included and between them there was a wide spread of overall ratios (range 0-130%). The general tendency was for under-reporting on Yellow Cards but for ADRs with a fatal outcome this appeared to be less (range 7-168%). CONCLUSIONS: This study provides some broad indications of the degree of under-reporting of ADRs that occurs despite a clinical diagnosis of a serious ADR being made and recorded.
Authors: C C Smith; P M Bennett; H M Pearce; P I Harrison; D J Reynolds; J K Aronson; D G Grahame-Smith Journal: Br J Clin Pharmacol Date: 1996-10 Impact factor: 4.335
Authors: Shirley J Simmonds; Holly E Syddall; Leo D Westbury; Richard M Dodds; Cyrus Cooper; Avan Aihie Sayer Journal: Age Ageing Date: 2015-11 Impact factor: 10.668
Authors: Corinne M Hohl; Andrei Karpov; Lisa Reddekopp; Mimi Doyle-Waters; Jürgen Stausberg Journal: J Am Med Inform Assoc Date: 2013-11-12 Impact factor: 4.497